CN110974894A - Traditional Chinese medicine composition for treating diabetes combined with cerebral infarction - Google Patents
Traditional Chinese medicine composition for treating diabetes combined with cerebral infarction Download PDFInfo
- Publication number
- CN110974894A CN110974894A CN201911426552.8A CN201911426552A CN110974894A CN 110974894 A CN110974894 A CN 110974894A CN 201911426552 A CN201911426552 A CN 201911426552A CN 110974894 A CN110974894 A CN 110974894A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- composition
- ginseng
- cerebral infarction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
The invention discloses a traditional Chinese medicine composition for treating diabetes combined cerebral infarction, which comprises a first composition and a second composition, wherein the first composition comprises the following traditional Chinese medicines in parts by weight: 30-48 parts of ginseng, 22-47 parts of mulberry leaf extract, 10-20 parts of golden sunflower flower, 10-30 parts of cortex lycii radicis, 15-38 parts of astragalus membranaceus, 15-40 parts of purslane, 10-25 parts of stiff silkworm powder, 18-28 parts of radix astragali, 17-33 parts of radix rehmanniae, 18-40 parts of salvia miltiorrhiza and 18-33 parts of angelica sinensis, wherein the composition II comprises the following traditional Chinese medicines in parts by weight: 15-40 parts of pseudo-ginseng, 20-30 parts of salvia miltiorrhiza, 17-40 parts of safflower, 18-37 parts of suberect spatholobus stem, 5-13 parts of costustoot, 17-40 parts of grassleaf sweelflag rhizome and 30-55 parts of epimedium herb. According to the invention, the traditional Chinese medicines in the composition I and the composition II are cleaned and dried, sterilized and disinfected, then crushed and ground, and then uniformly mixed, and finally taken according to the patient condition adaptability; solves the problems of slow effect, long treatment course and complex process of the traditional Chinese patent medicine in the actual use process, and brings inconvenience to production and taking.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating diabetes combined with cerebral infarction.
Background
Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is caused by a defect in insulin secretion or an impaired biological action, or both. Hyperglycemia occurring over a long period of time in diabetes causes chronic damage to, dysfunction of, various tissues, particularly, the eyes, kidneys, heart, blood vessels, nerves; cerebral infarction is also called ischemic stroke, which is called stroke or stroke in traditional Chinese medicine. The disease is caused by blood supply disorder of local brain tissue areas caused by various reasons, and the ischemic and hypoxic lesion necrosis of the brain tissue is caused, so that the clinically corresponding nerve function deficiency expression is generated. Cerebral infarction is divided into main types such as cerebral thrombosis, cerebral embolism, lacunar infarction and the like according to different pathogenesis. Among them, cerebral thrombosis is the most common type of cerebral infarction, accounting for about 60% of all cerebral infarctions, and thus the so-called 'cerebral infarction' actually refers to cerebral thrombosis. Cerebral thrombosis is used for narrative emphasis, and related problems of cerebral infarction are described in detail;
with the intensive research on diabetes, it is found that the blood sugar is increased for a long time, and large blood vessels and micro blood vessels are damaged and endanger the heart, the brain, the kidney, peripheral nerves, eyes, feet and the like, and according to the statistics of the world health organization, the diabetes complication is more than 100, and is one of the most known complications at present. More than half of the deaths from diabetes are caused by cardiovascular and cerebrovascular diseases, and a large part of the cardiovascular and cerebrovascular diseases cause asymptomatic stroke, which means stroke without clinical symptoms or slight symptoms, which is not noticed and thus not revealed or identified. Wherein, the asymptomatic cerebral infarction (including lacunar cerebral infarction and non-lacunar cerebral infarction) accounts for 74 percent, and the asymptomatic cerebral hemorrhage accounts for 26 percent; cerebral infarction caused by diabetes can be treated mainly by traditional Chinese medicines and by matching with western medicines, but the traditional Chinese patent medicine has slow effect, longer treatment course and more complex process, and brings inconvenience to production and taking.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine composition for treating diabetes combined with cerebral infarction, which improves the traditional device and solves the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme: a traditional Chinese medicine composition for treating diabetes combined cerebral infarction comprises a first composition and a second composition, wherein the first composition comprises the following traditional Chinese medicines in parts by weight: 30-48 parts of ginseng, 22-47 parts of mulberry leaf extract, 10-20 parts of goldenrod flower, 10-30 parts of cortex lycii radicis, 15-38 parts of astragalus membranaceus, 15-40 parts of purslane, 10-25 parts of stiff silkworm powder, 18-28 parts of radix astragali, 17-33 parts of radix rehmanniae, 18-40 parts of salvia miltiorrhiza and 18-33 parts of angelica;
the composition II comprises the following traditional Chinese medicines in parts by weight: 15-40 parts of pseudo-ginseng, 20-30 parts of salvia miltiorrhiza, 17-40 parts of safflower, 18-37 parts of suberect spatholobus stem, 5-13 parts of costustoot, 17-40 parts of grassleaf sweelflag rhizome and 30-55 parts of epimedium herb.
Preferably, the first composition comprises the following traditional Chinese medicines in parts by weight: 35-43 parts of ginseng, 23-41 parts of mulberry leaf extract, 13-17 parts of goldenrod flower, 18-25 parts of cortex lycii radicis, 19-29 parts of astragalus membranaceus, 19-33 parts of purslane, 17-20 parts of stiff silkworm powder, 22-25 parts of radix astragali, 19-27 parts of radix rehmanniae, 22-35 parts of salvia miltiorrhiza and 25-30 parts of angelica sinensis.
Preferably, the second composition comprises the following traditional Chinese medicines in parts by weight: 18-35 parts of pseudo-ginseng, 23-30 parts of salvia miltiorrhiza, 22-30 parts of safflower, 28-35 parts of suberect spatholobus stem, 8-10 parts of costustoot, 25-37 parts of grassleaf sweelflag rhizome and 33-50 parts of epimedium herb.
Preferably, the first composition comprises the following traditional Chinese medicines in parts by weight: 40 parts of ginseng, 33 parts of mulberry leaf extract, 15 parts of golden sunflower seed, 22 parts of cortex lycii radicis, 27 parts of astragalus membranaceus, 25 parts of purslane, 18 parts of stiff silkworm powder, 13 parts of radix astragali, 25 parts of radix rehmanniae, 30 parts of salvia miltiorrhiza and 28 parts of angelica sinensis.
Preferably, the second composition comprises the following traditional Chinese medicines in parts by weight: 30 parts of pseudo-ginseng, 25 parts of salvia miltiorrhiza, 27 parts of safflower, 33 parts of suberect spatholobus stem, 9 parts of costustoot, 30 parts of grassleaf sweelflag rhizome and 43 parts of epimedium herb.
Compared with the prior art, the invention has the following beneficial effects:
the traditional Chinese medicines in the composition I and the composition II are matched with each other, so that on one hand, the blood sugar in the body of a patient can be reduced, the blood sugar can be maintained at a stable level, on the other hand, the absorption of hematoma and edema around a cerebral infarction focus can be accelerated, the channels and collaterals are dredged, the pain is relieved, the effect is fast, and the discomfort of the patient is relieved;
the ginseng in the composition I provided by the invention is a perennial root herb, the main root of the ginseng is 30-60 cm high, is fat, fleshy, yellow-white, cylindrical or spindle-shaped, and slightly branched below; the rhizome (the reed head) is short and upright, and the insulin in the endocrine system of a patient is regulated through the medicinal ingredients in the ginseng, so that the blood sugar level of the patient is effectively controlled;
the mulberry leaf extract, mulberry leaf and traditional Chinese medicine are dry leaves of mulberry of Moraceae, are daily food of silkworm, and have strong antioxidant effect. The product is rich in rare organic selenium and germanium, is natural strong antioxidant, and can scavenge free radicals in vivo, oxidize toxin and waste accumulated in human body, increase oxygen content in blood, and promote metabolism and microcirculation. Has obvious effects on hyperlipemia, hyperglycemia, fatty liver and coronary heart disease;
flos Helianthi, flos Helianthi is a plant of Abelmoschus of family Malvaceae of annual herbaceous Malvaceae, contains multiple bioactive substances, has bioflavonoid content of up to 6%, and has effects of remarkably regulating endocrine and immunity of human body, increasing resistance of human body, and improving cardiovascular and cerebrovascular and microcirculation functions;
cortex Lycii, also known as Chinese wolfberry bark, is a plant of genus Lycium of family Solanaceae; has the effects of clearing heat and cooling blood. Can be used for treating hectic fever due to asthenia, night sweat, cough and asthma due to lung heat, hematemesis, epistaxis, stranguria with blood, diabetes, hypertension, carbuncle, and malignant boil;
the astragalus has obvious curative effects on diseases such as exterior deficiency spontaneous perspiration, internal injury due to qi deficiency, listlessness, myasthenia of limbs, spleen deficiency diarrhea, body deficiency hyperhidrosis, qi deficiency rectocele, edema, carbuncle, cellulitis and the like;
the purslane is also called purslane, is a plant used as both medicine and food and is mainly used for treating heat toxin diarrhea; hot spraying; anuria; leucorrhea with reddish discharge; (ii) metrorrhagia and metrostaxis; hemorrhoidal bleeding; sores, ulcers, carbuncles and furuncles;
the stiff silkworm is also called stiff worm or tencell in some places of China, can effectively treat the conditions of weakness of the whole body, feeling tired and the like, contains a large amount of ammonium oxalate and hydrolase, can promote the health of people after being taken, plays the roles of removing stasis and resolving powder, dispelling wind and relieving spasm, and is ground into powder when in use;
astragalus membranaceus, also called Astragalus membranaceus, and Astragalus membranaceus, is one of the commonly used Chinese medicinal materials for treating spontaneous perspiration and qi deficiency and other diseases caused by weak qi and weak exterior. Clinically, the jade screen powder is prepared from astragalus, divaricate saposhnikovia root and largehead atractylodes rhizome and is used for treating patients with exterior deficiency, spontaneous perspiration and susceptibility to wind-cold;
the rehmannia root is named as radix rehmanniae, wild rehmannia root, mountain tobacco root and the like, is the root tuber of rehmannia root of Scrophulariaceae, has the effects of clearing heat and cooling blood, is used for treating heat entering nutrient blood in warm diseases, has high fever and unconsciousness, and has a dry mouth and a crimson tongue; can be used for treating warm diseases with heat entering nutrient-blood, blood heat and toxic materials, hematemesis and epistaxis, and macula purple black;
red sage root, name of Chinese traditional medicine. Is the dried root and rhizome of Salvia miltiorrhiza Bunge of Labiatae, and has effects of promoting blood circulation, removing blood stasis, dredging channels, relieving pain, clearing heart fire, relieving restlessness, cooling blood, and resolving carbuncle. Can be used for treating thoracic obstruction, heart pain, abdominal pain, hypochondriac pain, abdominal mass, pain due to pyretic arthralgia, vexation, insomnia, menoxenia, dysmenorrhea, amenorrhea, and pyocutaneous disease with swelling and pain;
angelica, also called dry angelica, is a perennial umbelliferae herb, the root of which can be used as a medicine, is one of the most common traditional Chinese medicines, and has the efficacies of blood tonifying and blood regulating, menstruation regulating, pain relieving, dryness moistening, intestine smoothing, cancer resistance, aging resistance and immunity;
the pseudo-ginseng provided by the invention is a plant of the Araliaceae family, so the pseudo-ginseng is named as wenshan pseudo-ginseng. Sweet in taste, bitter in taste and warm in nature, and has the effects of stopping bleeding, relieving pain, promoting blood circulation and removing blood stasis;
red sage root, name of Chinese traditional medicine. Is dried root and rhizome of Labiatae plant. Collected in spring and autumn, removed of silt and dried. Distributed throughout most parts of the country. Has the effects of activating blood circulation to dissipate blood stasis, stimulating the menstrual flow to relieve pain, clearing away the heart-fire and relieving restlessness, cooling blood and eliminating carbuncle. Can be used for treating thoracic obstruction, heart pain, abdominal pain, hypochondriac pain, abdominal mass, pain due to pyretic arthralgia, vexation, insomnia, menoxenia, dysmenorrhea, amenorrhea, and pyocutaneous disease with swelling and pain.
Safflower, safflower is warm in nature and pungent in flavor, also enters heart meridian, is pungent in flavor and warm in nature and can activate blood and dredge meridian, remove stasis and relieve pain;
caulis Spatholobi is a plant of Millettia of Leguminosae, and can be used for treating rheumatalgia, numbness of limbs, paralysis of limbs, and sallow complexion due to blood deficiency.
Radix aucklandiae is root of Compositae plant radix aucklandiae, cylindrical or flat cylindrical, and is used for promoting circulation of qi and relieving pain; to regulate the middle energizer and remove food stagnation. Hypochondriac distention in the main cell is satisfied; abdominal distending pain; belching, vomiting and diarrhea; severe after dysentery. Can be used for treating chest and abdominal pain, dysentery, tenesmus, dyspepsia, and anorexia; the middle-jiao energy is not saved;
acorus gramineus L.of Araceae and Acorus gramineus of grass-shaped perennial herb has obvious effect on heart and cerebral vessels. The traditional Chinese medicine is clinically used for treating coronary heart disease, pulmonary heart disease and other thoracic impediments due to turbid phlegm and qi stagnation, and the mechanism of the traditional Chinese medicine is possibly related to the increase of coronary blood flow, and also possibly related to the effects of calming, improving digestive function, relieving asthma, relieving cough and the like;
herba Epimedii is a Chinese medicinal material, mainly contains flavonoids, lignanoid, alkaloid, volatile oil, etc., has pungent, sweet and warm properties, has effects of invigorating kidney yang, strengthening tendons and bones, and dispelling pathogenic wind, and can be used for treating sexual impotence, spermatorrhea, tendons and bones debility soft, rheumatalgia, numbness and spasm due to kidney yang deficiency
Fourthly, the traditional Chinese medicines in the composition I and the composition II are cleaned, dried, sterilized, disinfected, crushed and ground, and then are mixed evenly, and finally the medicine is taken according to the patient condition adaptability;
the invention solves the problem that the traditional Chinese patent medicine is inconvenient to produce and take due to slow effect taking, long treatment course and complex process in the actual use process by matching the composition I and the composition II.
Drawings
FIG. 1 is a chart of the parts of the ingredients of a Chinese medicinal composition of the present invention;
FIG. 2 is a chart showing the parts of the two Chinese medicinal materials of the composition of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention will be further illustrated with reference to specific examples:
the first embodiment is as follows:
referring to fig. 1 to 2, the present invention provides a technical solution: a traditional Chinese medicine composition for treating diabetes combined cerebral infarction comprises a first composition and a second composition, wherein the first composition comprises the following traditional Chinese medicines in parts by weight: 30-48 parts of ginseng, 22-47 parts of mulberry leaf extract, 10-20 parts of goldenrod flower, 10-30 parts of cortex lycii radicis, 15-38 parts of astragalus membranaceus, 15-40 parts of purslane, 10-25 parts of stiff silkworm powder, 18-28 parts of radix astragali, 17-33 parts of radix rehmanniae, 18-40 parts of salvia miltiorrhiza and 18-33 parts of angelica;
the composition II comprises the following traditional Chinese medicines in parts by weight: 18-35 parts of pseudo-ginseng, 23-30 parts of salvia miltiorrhiza, 22-30 parts of safflower, 28-35 parts of suberect spatholobus stem, 8-10 parts of costustoot, 25-37 parts of grassleaf sweelflag rhizome and 33-50 parts of epimedium herb.
Example two:
a traditional Chinese medicine composition for treating diabetes combined cerebral infarction comprises a first composition and a second composition, wherein the first composition comprises the following traditional Chinese medicines in parts by weight: 30-48 parts of ginseng, 22-47 parts of mulberry leaf extract, 10-20 parts of goldenrod flower, 10-30 parts of cortex lycii radicis, 15-38 parts of astragalus membranaceus, 15-40 parts of purslane, 10-25 parts of stiff silkworm powder, 18-28 parts of radix astragali, 17-33 parts of radix rehmanniae, 18-40 parts of salvia miltiorrhiza and 18-33 parts of angelica;
the composition II comprises the following traditional Chinese medicines in parts by weight: 30 parts of pseudo-ginseng, 25 parts of salvia miltiorrhiza, 27 parts of safflower, 33 parts of suberect spatholobus stem, 9 parts of costustoot, 30 parts of grassleaf sweelflag rhizome and 43 parts of epimedium herb.
Example three:
a traditional Chinese medicine composition for treating diabetes combined cerebral infarction comprises a first composition and a second composition, wherein the first composition comprises the following traditional Chinese medicines in parts by weight: 35-43 parts of ginseng, 23-41 parts of mulberry leaf extract, 13-17 parts of goldenrod flower, 18-25 parts of cortex lycii radicis, 19-29 parts of astragalus membranaceus, 19-33 parts of purslane, 17-20 parts of stiff silkworm powder, 22-25 parts of radix astragali, 19-27 parts of radix rehmanniae, 22-35 parts of salvia miltiorrhiza and 25-30 parts of angelica;
the composition II comprises the following traditional Chinese medicines in parts by weight: 18-35 parts of pseudo-ginseng, 23-30 parts of salvia miltiorrhiza, 22-30 parts of safflower, 28-35 parts of suberect spatholobus stem, 8-10 parts of costustoot, 25-37 parts of grassleaf sweelflag rhizome and 33-50 parts of epimedium herb.
Example four:
a traditional Chinese medicine composition for treating diabetes combined cerebral infarction comprises a first composition and a second composition, wherein the first composition comprises the following traditional Chinese medicines in parts by weight: 35-43 parts of ginseng, 23-41 parts of mulberry leaf extract, 13-17 parts of goldenrod flower, 18-25 parts of cortex lycii radicis, 19-29 parts of astragalus membranaceus, 19-33 parts of purslane, 17-20 parts of stiff silkworm powder, 22-25 parts of radix astragali, 19-27 parts of radix rehmanniae, 22-35 parts of salvia miltiorrhiza and 25-30 parts of angelica;
the composition II comprises the following traditional Chinese medicines in parts by weight: 30 parts of pseudo-ginseng, 25 parts of salvia miltiorrhiza, 27 parts of safflower, 33 parts of suberect spatholobus stem, 9 parts of costustoot, 30 parts of grassleaf sweelflag rhizome and 43 parts of epimedium herb.
Example five:
a traditional Chinese medicine composition for treating diabetes combined cerebral infarction comprises a first composition and a second composition, wherein the first composition comprises the following traditional Chinese medicines in parts by weight: 40 parts of ginseng, 33 parts of mulberry leaf extract, 15 parts of golden sunflower seed, 22 parts of cortex lycii radicis, 27 parts of astragalus, 25 parts of purslane, 18 parts of stiff silkworm powder, 13 parts of astragalus, 25 parts of radix rehmanniae, 30 parts of salvia miltiorrhiza and 28 parts of angelica;
the composition II comprises the following traditional Chinese medicines in parts by weight: 30 parts of pseudo-ginseng, 25 parts of salvia miltiorrhiza, 27 parts of safflower, 33 parts of suberect spatholobus stem, 9 parts of costustoot, 30 parts of grassleaf sweelflag rhizome and 43 parts of epimedium herb.
The working principle is as follows: when the traditional Chinese medicine composition for treating diabetes combined with cerebral infarction is used, the traditional Chinese medicines in the composition I and the composition II are matched with each other, so that on one hand, the blood sugar in the body of a patient can be reduced and maintained at a stable level, and on the other hand, the absorption of hematoma and edema around the cerebral infarction focus can be accelerated, the channels and collaterals are dredged, the pain is relieved, the effect is fast, and the discomfort of the patient is relieved; the traditional Chinese medicines in the composition I and the composition II are cleaned, dried, sterilized, disinfected, crushed and ground, and then are mixed uniformly, and finally taken according to the patient's disease condition adaptability; through the matching of the first composition and the second composition, the problem that the traditional Chinese patent medicine is inconvenient to produce and take because of slow effect, long treatment course and complex process in the actual use process is solved.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (5)
1. A traditional Chinese medicine composition for treating diabetes combined with cerebral infarction is characterized in that: the traditional Chinese medicine composition comprises a first composition and a second composition, wherein the first composition comprises the following traditional Chinese medicines in parts by weight: 30-48 parts of ginseng, 22-47 parts of mulberry leaf extract, 10-20 parts of goldenrod flower, 10-30 parts of cortex lycii radicis, 15-38 parts of astragalus membranaceus, 15-40 parts of purslane, 10-25 parts of stiff silkworm powder, 18-28 parts of radix astragali, 17-33 parts of radix rehmanniae, 18-40 parts of salvia miltiorrhiza and 18-33 parts of angelica;
the composition II comprises the following traditional Chinese medicines in parts by weight: 15-40 parts of pseudo-ginseng, 20-30 parts of salvia miltiorrhiza, 17-40 parts of safflower, 18-37 parts of suberect spatholobus stem, 5-13 parts of costustoot, 17-40 parts of grassleaf sweelflag rhizome and 30-55 parts of epimedium herb.
2. The traditional Chinese medicine composition for treating diabetes combined with cerebral infarction according to claim 1, which is characterized in that: the first composition comprises the following traditional Chinese medicines in parts by weight: 35-43 parts of ginseng, 23-41 parts of mulberry leaf extract, 13-17 parts of goldenrod flower, 18-25 parts of cortex lycii radicis, 19-29 parts of astragalus membranaceus, 19-33 parts of purslane, 17-20 parts of stiff silkworm powder, 22-25 parts of radix astragali, 19-27 parts of radix rehmanniae, 22-35 parts of salvia miltiorrhiza and 25-30 parts of angelica sinensis.
3. The traditional Chinese medicine composition for treating diabetes combined with cerebral infarction according to claim 1, which is characterized in that: the composition II comprises the following traditional Chinese medicines in parts by weight: 18-35 parts of pseudo-ginseng, 23-30 parts of salvia miltiorrhiza, 22-30 parts of safflower, 28-35 parts of suberect spatholobus stem, 8-10 parts of costustoot, 25-37 parts of grassleaf sweelflag rhizome and 33-50 parts of epimedium herb.
4. The traditional Chinese medicine composition for treating diabetes combined with cerebral infarction according to claim 1, which is characterized in that: the first composition comprises the following traditional Chinese medicines in parts by weight: 40 parts of ginseng, 33 parts of mulberry leaf extract, 15 parts of golden sunflower seed, 22 parts of cortex lycii radicis, 27 parts of astragalus membranaceus, 25 parts of purslane, 18 parts of stiff silkworm powder, 13 parts of radix astragali, 25 parts of radix rehmanniae, 30 parts of salvia miltiorrhiza and 28 parts of angelica sinensis.
5. The traditional Chinese medicine composition for treating diabetes combined with cerebral infarction according to claim 1, which is characterized in that: the composition II comprises the following traditional Chinese medicines in parts by weight: 30 parts of pseudo-ginseng, 25 parts of salvia miltiorrhiza, 27 parts of safflower, 33 parts of suberect spatholobus stem, 9 parts of costustoot, 30 parts of grassleaf sweelflag rhizome and 43 parts of epimedium herb.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911426552.8A CN110974894A (en) | 2019-12-30 | 2019-12-30 | Traditional Chinese medicine composition for treating diabetes combined with cerebral infarction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911426552.8A CN110974894A (en) | 2019-12-30 | 2019-12-30 | Traditional Chinese medicine composition for treating diabetes combined with cerebral infarction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110974894A true CN110974894A (en) | 2020-04-10 |
Family
ID=70080338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911426552.8A Withdrawn CN110974894A (en) | 2019-12-30 | 2019-12-30 | Traditional Chinese medicine composition for treating diabetes combined with cerebral infarction |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110974894A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115414407A (en) * | 2022-09-23 | 2022-12-02 | 翟阳 | Zhuang medicine compound medicine for treating ischemic stroke and preparation method thereof |
-
2019
- 2019-12-30 CN CN201911426552.8A patent/CN110974894A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115414407A (en) * | 2022-09-23 | 2022-12-02 | 翟阳 | Zhuang medicine compound medicine for treating ischemic stroke and preparation method thereof |
| CN115414407B (en) * | 2022-09-23 | 2023-08-22 | 翟阳 | Zhuang medicine compound medicine for treating ischemic cerebral apoplexy and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108030864B (en) | Zhuang medicine liquid for treating traumatic injury, burn and inflammation | |
| CN104352776B (en) | A kind of hypomenorrhia for the treatment of causes infertile Chinese medicine preparation and preparation method thereof | |
| CN104758854A (en) | Chinese herba preparation for treating premature ovarian failure | |
| CN104940740A (en) | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and preparation method thereof | |
| CN107715014A (en) | A kind of Chinese medicine composition for gout and preparation method thereof | |
| CN110974894A (en) | Traditional Chinese medicine composition for treating diabetes combined with cerebral infarction | |
| CN104173957A (en) | Anti-senile life-prolonging plaster | |
| CN107320631B (en) | Anti-fatigue traditional Chinese medicine composition and preparation method thereof | |
| CN105412859A (en) | Chinese medicine composition for preventing and treating postpartum puerperal fever and preparation method thereof | |
| CN104984265A (en) | Traditional Chinese medicine preparation for cutaneous hemangioma and preparation method thereof | |
| CN104523873A (en) | Pharmaceutical composition for treating gout | |
| CN103656197B (en) | The Chinese medicine composition of kidney tonifying and enriching blood and preparation method | |
| CN105169338A (en) | Medicine composition for treating female climacteric syndromes and preparation method thereof | |
| CN104958677A (en) | Traditional Chinese medicine preparation for treating membranous nephropathy and preparation method of traditional Chinese medicine preparation | |
| CN111084865A (en) | Pharmaceutical composition for postpartum recovery and preparation method and application thereof | |
| CN104984027A (en) | Chinese materia medica preparation for treating myelodysplastic syndrome and preparation method thereof | |
| CN110585285A (en) | A Chinese medicinal composition for consolidating hair, promoting hair growth, nourishing hair, blackening hair, regulating stomach and tranquilizing mind, and its preparation method | |
| CN104306583A (en) | Traditional Chinese medicine composition for treating scanty menstruation and preparation method of traditional Chinese medicine composition | |
| CN104435709A (en) | Nourishing and hair-blacking tablet and preparation method thereof | |
| CN104840891A (en) | Traditional Chinese medicine preparation used for treating alcoholic cardiomyopathy and preparation method thereof | |
| CN104971340B (en) | A kind of Chinese medicine preparation and preparation method thereof for treating diarrhea associated with menstruation | |
| CN104606600A (en) | Traditional Chinese medicine composition for treating interstitial lung disease and preparation method of composition | |
| CN107823330A (en) | A kind of red bone sheep bone kidney-reinforcing medicinal liquor and preparation method thereof | |
| CN108704040B (en) | Traditional Chinese medicine composition and application thereof | |
| CN104873770A (en) | Traditional Chinese medicine preparation for radioactive leucopenia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200410 |